XML 48 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note 10. Stock-based Compensation
9 Months Ended
Sep. 30, 2015
Notes  
Note 10. Stock-based Compensation

Note 10.  Stock-Based Compensation

 

Our Third Amended and Restated 1998 Stock Incentive Plan (“Plan”) authorizes the granting of incentive stock options to certain key employees and non-employees who provide services to the Company.  The Plan, as amended, provides for the granting of options for an aggregate 633,730 shares.  The options vest subject to management’s discretion.

As of September 30, 2015, we had approximately 116,541 shares of common stock reserved for future issuance under the Plan.  Also, in connection with our appointment of a Chief Executive Officer in November 2014, we issued an inducement equity award in the form of a non-statutory stock option to purchase 140,000 shares of the Company’s stock.  This grant was outside the Company’s stock incentive plans, and was in accordance with the NASDAQ inducement grant exception found in NASDAQ Listing Rule 5635(c)(4).

Effective February 4, 2009, our Fourth Amended and Restated 1998 Directors Stock Plan (the “Director Plan”) provides an annual retainer of $60,000 to each non-employee director with the exception of the Audit Committee Chairman who is to receive $65,000.  The cash portion of the compensation of $30,000 ($35,000 for the Audit Committee Chairman) is paid 50% twice each year, with $30,000 of compensation paid in common stock of the Company once each year.  Prior to February 4, 2009, the Director Plan granted each non-employee outside director 3,000 options each year at an exercise price equal to the fair market value of the common stock at the date the option was granted.  The options vest according to a set schedule over a five-year period and expire upon the director’s termination, or after ten years from the date of grant.  The Director Plan, as amended, allows for an aggregate of 175,000 shares to be granted.  This Director Plan terminated effective August 31, 2015.

Stock-based compensation cost is measured at the grant date based on the estimated value of the award granted, using the Black-Scholes option pricing model, and recognized over the period in which the award vests.  For stock awards no longer expected to vest, any previously recognized stock compensation expense is reversed in the period of termination. 

The stock-based compensation expense has been allocated to the various categories of operating costs and expenses in a manner similar to the allocation of payroll expense as follows:

 

Three Months Ended September 30,

Nine Months Ended September 30,

 

2015

2014

2015

2014

 

 

 

 

 

Cost of sales

$          5,142

$        12,968

$        18,855

$        43,592

Research and development

12,711

38,549

40,165

129,831

Selling, general and administrative

97,456

125,627

320,742

424,397

 

 

 

 

 

Total

$      115,309

$      177,144

$      379,762

$      597,820

 

 

During the nine months ended September 30, 2015, we granted employees a total of 114,250 stock options at a weighted average exercise price of $3.27 per share, with one third vesting each year for the next three years.  The estimated weighted average grant date fair value per share of these stock options was $1.55, and our weighted average assumptions used in the Black-Scholes valuation model to determine this estimated fair value were as follows:

 

Expected volatility

63.25%

Expected dividends

0%

Expected term

7.24 years

Risk-free interest rate

1.88%

 

Unrecognized stock-based compensation expense expected to be recognized over the estimated weighted-average amortization period of 1.81 years is approximately $725,000 as of September 30, 2015.

 

A summary of the time-based stock option awards as of September 30, 2015, and changes during the nine months then ended, is as follows:

 

Shares

Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contract Term (Years)

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

Outstanding at December 31, 2014

513,193

$

22.46

7.03

 

 

Granted

114,250

 

  3.27

 

 

 

Exercised

           -

 

      -

 

 

 

Forfeited or expired

  (103,501)

 

37.81

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2015

523,942

$

  15.24

6.82

$

7,245

 

 

 

 

 

 

 

Exercisable at September 30, 2015

229,647

$

  28.02

3.87

$

-

 

           

The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on our closing stock price of $1.85 as of September 30, 2015, which would have been received by the holders of in-the-money options had the option holders exercised their options as of that date.